Cargando…
Genome‐wide gain‐of‐function screening identifies EZH2 mediating resistance to PI3Kα inhibitors in oesophageal squamous cell carcinoma
Phosphoinositide‐3 kinase alpha (PI3Kα) has been confirmed to be a potential therapeutic target for esophageal squamous cell carcinoma (ESCC), while the potency of PI3Kα inhibitors is often attenuated by concurrent oncogenic signalling pathways. We performed genome‐wide gain‐of‐function screening wi...
Autores principales: | Xing, Hui, Gao, Mengshi, Wang, Yuxiang, Zhang, Xu, Shi, Jiajie, Wang, Xiang, Liu, Xueling, Ma, Qingyang, Kong, Xiangyin, Yang, Chunhao, Ding, Jian, Meng, Linghua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126361/ https://www.ncbi.nlm.nih.gov/pubmed/35604910 http://dx.doi.org/10.1002/ctm2.835 |
Ejemplares similares
-
Intact regulation of G1/S transition renders esophageal squamous cell carcinoma sensitive to PI3Kα inhibitors
por: Zhang, Xu, et al.
Publicado: (2023) -
Simultaneous inhibition of PI3Kα and CDK4/6 synergistically suppresses KRAS-mutated non-small cell lung cancer
por: Wang, Yuxiang, et al.
Publicado: (2019) -
Erratum to Simultaneous inhibition of PI3Kα and CDK4/6 synergistically suppresses KRAS-mutated non-small cell lung cancer
por: Wang, Yuxiang, et al.
Publicado: (2019) -
Prognostic significance of EZH2 expression in patients with oesophageal cancer: a meta‐analysis
por: Wang, Yawei, et al.
Publicado: (2016) -
Laminin-332 promotes the invasion of oesophageal squamous cell carcinoma via PI3K activation
por: Baba, Y, et al.
Publicado: (2008)